CLAZAKIZUMAB (CLZ, ANTI-IL-6) AND TOCILIZUMAB (TCZ, ANTI-IL-6 RECEPTOR) DIFFERENTIALLY AFFECT IL-6/IL-6R SIGNALING BY MODULATING SOLUBLE IL-6R & GP130 IN PATIENTS TREATED FOR CHRONIC ANTIBODY-MEDIATED REJECTION (CABMR)

被引：0
|
作者：
Shin, Bongha [1 ]
Vo, Ashley [1 ]
Ge, Shili [1 ]
Petrosyan, Anna [1 ]
Ammerman, Noriko [1 ]
Jordan, Stanley [1 ]
Toyoda, Mieko [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
LBP023
引用
收藏
页码：410 / 410
页数：1
相关论文
共 50 条
  • [21] Molecular and functional characterization of IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) in Nile tilapia (Oreochromis niloticus)
    Zhou, Enxu
    Yan, Fangfang
    Li, Bingxi
    Chen, Meng
    Tu, Xiao
    Wu, Siwei
    Wu, Hairong
    Wei, Xiufang
    Fu, Shengli
    Wu, Liting
    Guo, Zheng
    Ye, Jianmin
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2020, 106
  • [22] Differentially Expressed IL-6Rα and GP130 Genes in Kidney Biopsies (Bxs) Suggests Different Roles of IL-6 Signaling in Antibody (ABMR)- and Cell (CMR)-Mediated Rejection
    Zhang, H.
    Thomas, D.
    Kowalewska, J.
    Suviolahti, E.
    Shafi, H.
    Nast, C.
    Gertych, A.
    Vo, A.
    Haas, M.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [23] Cell-surface levels of IL-6R and gp130 are differentially controlled by endocytosis and recycling in dependence upon IL-6
    Flynn, Charlotte Margaret Joan
    Daunke, Tina
    Kespohl, Birte
    Rose-John, Stefan
    Garbers, Christoph
    Aparicio-Siegmund, Samadhi
    CYTOKINE, 2017, 100 : 145 - 145
  • [24] A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects
    Rafiq, S.
    Frayling, T. M.
    Murray, A.
    Hurst, A.
    Stevens, K.
    Weedon, M. N.
    Henley, W.
    Ferrucci, L.
    Bandinelli, S.
    Corsi, A-M
    Guralnik, J. M.
    Melzer, D.
    GENES AND IMMUNITY, 2007, 8 (07) : 552 - 559
  • [25] Immunoadhesins of interleukin-6 and the IL-6 soluble IL-6R fusion protein hyper-IL-6
    Jostock, T
    Blinn, G
    Renné, C
    Kallen, KJ
    Rose-John, S
    Müllberg, J
    JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 223 (02) : 171 - 183
  • [26] Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production
    Uchiyama, Yasushi
    Yoshida, Hiroto
    Koike, Nobuo
    Hayakawa, Naohiko
    Sugita, Atsuko
    Nishimura, Takashi
    Mihara, Masahiko
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (11) : 1595 - 1601
  • [27] INTERLEUKIN-6 (IL-6) AND ITS RECEPTOR (IL-6R) IN MYELOMA PLASMACYTOMA
    SUEMATSU, S
    HIBI, M
    SUGITA, T
    SAITO, M
    MURAKAMI, M
    MATSUSAKA, T
    MATSUDA, T
    HIRANO, T
    TAGA, T
    KISHIMOTO, T
    CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1990, 166 : 13 - 22
  • [28] IL-6 AND IL-6 RECEPTOR (IL-6R) EXPRESSION AND MODULATION DURING ACUTE-INFLAMMATION IN THE RAT
    GEISTERFER, M
    RICHARDS, C
    BAUMANN, M
    FEY, G
    GWYNNE, D
    GAULDIE, J
    FASEB JOURNAL, 1992, 6 (05): : A1896 - A1896
  • [29] Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors
    Kimura, T
    Wang, JF
    Minamiguchi, H
    Fujiki, H
    Harada, S
    Okuda, K
    Kaneko, H
    Yokota, S
    Yasukawa, K
    Abe, T
    Sonoda, Y
    STEM CELLS, 2000, 18 (06) : 444 - 452
  • [30] C/EBP, interleukin(IL)-6, IL-6R and Gp130 induction after reperfusion of ischemic myocardium
    Freeman, GL
    Colston, JT
    Chandrasekar, B
    CIRCULATION, 1997, 96 (08) : 1092 - 1092
12345